Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration
- DOI
- 10.3389/freae.2025.1691949
- Published
- 2025-10-30
- Container
- Frontiers in Epigenetics and Epigenomics
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/freae.2025.1691949,
title = {Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration},
author = {Muhammad Javid Iqbal and Luis A. Salazar},
year = {2025},
journal = {Frontiers in Epigenetics and Epigenomics},
doi = {10.3389/freae.2025.1691949},
url = {https://doi.org/10.3389/freae.2025.1691949}
}RIS
TY - JOUR TI - Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration AU - Muhammad Javid Iqbal AU - Luis A. Salazar PY - 2025 JO - Frontiers in Epigenetics and Epigenomics DO - 10.3389/freae.2025.1691949 UR - https://doi.org/10.3389/freae.2025.1691949 ER -
APA
Iqbal, M. J., & Salazar, L. A. (2025). Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2025.1691949
Source records
- crossref · retrieved 2026-09-26T21:44:43.451Z